Literature DB >> 12684417

Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.

Tamotsu Kuroki1, Francesco Trapasso, Sai Yendamuri, Ayumi Matsuyama, Hansjuerg Alder, Masaki Mori, Carlo M Croce.   

Abstract

PURPOSE: The RAS association domain family 1A (RASSF1A) gene, a candidate tumor suppressor gene, is frequently inactivated by hypermethylation of its promoter region in several human cancers. The aim of this study was to evaluate the promoter methylation status of the RASSF1A in esophageal squamous cell carcinoma. EXPERIMENTAL
DESIGN: We analyzed the methylation status of RASSF1A promoter by methylation-specific PCR in 23 esophageal squamous cell carcinoma cell lines and 48 primary tumors.
RESULTS: Hypermethylation of RASSF1A was found in 74% of cell lines and 52% of primary tumors. The presence of hypermethylation was statistically associated with loss of RASSF1A mRNA expression in both cell lines (P = 0.007) and primary tumors (P = 0.003). There was a statistically significant correlation between the presence of hypermethylation and tumor stage (P = 0.009).
CONCLUSIONS: Our findings suggest that epigenetic silencing of RASSF1A gene expression by promoter hypermethylation could play an important role in primary esophageal squamous cell carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684417

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  13 in total

1.  Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.

Authors:  Frederik C Roos; Andrew J Evans; Walburgis Brenner; Bill Wondergem; Jeffery Klomp; Pardeep Heir; Olga Roche; Christian Thomas; Heiko Schimmel; Kyle A Furge; Bin T Teh; Joachim W Thüroff; Christian Hampel; Michael Ohh
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma.

Authors:  Wei Guo; Lei Cui; Cong Wang; Yanli Guo; Supeng Shen; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2014-04-23       Impact factor: 5.150

Review 3.  Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.

Authors:  Yoshifumi Baba; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2013-01-05       Impact factor: 2.549

4.  Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma.

Authors:  Bo Li; Bing Wang; Li-Juan Niu; Lei Jiang; Chang-Chun Qiu
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 5.  Methylation in esophageal carcinogenesis.

Authors:  Da-Long Wu; Feng-Ying Sui; Xiao-Ming Jiang; Xiao-Hong Jiang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

6.  Methylation status and protein expression of RASSF1A in endometriosis.

Authors:  Y U Wu; Mingde Zhang; Xian Zhang; Zhenzhou Xu; Weiguo Jin
Journal:  Oncol Lett       Date:  2016-04-28       Impact factor: 2.967

Review 7.  Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.

Authors:  De-Chen Lin; Ming-Rong Wang; H Phillip Koeffler
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 33.883

Review 8.  Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.

Authors:  Ji-Sheng Li; Jian-Ming Ying; Xiu-Wen Wang; Zhao-Hui Wang; Qian Tao; Li-Li Li
Journal:  Chin J Cancer       Date:  2012-05-08

Review 9.  Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.

Authors:  Jalil Pirayesh Islamian; Mohsen Mohammadi; Behzad Baradaran
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

Review 10.  The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.

Authors:  Kai Ma; Baoping Cao; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2016-04-22       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.